Contact lens wear continues to be a significant risk factor for the development of acute sight-threatening corneal infections (microbial keratitis).1–7 For more than 20 years, we and others in this field have worked toward understanding why the corneas of contact lens wearers are more susceptible to infection.8–14
Two major stumbling blocks have hindered progress in this field. The first is the lack of basic knowledge about how the healthy ocular surface normally defends itself against infection. Naturally, it is difficult to draw conclusions about how lens wear might impact defenses that have not yet been defined. A contributor to this problem has been our sketchy understanding of the normal biochemistry and cell biology of the ocular surface, combined with a lack of tools for sorting out which of the many factors present at the ocular surface were critical to defense against infection. Researchers in the field have therefore resorted to making educated guesses as to what molecules, processes, or cells to focus on. Sometimes associated “markers” have been examined that later turned out to have little to do with the mechanism being studied.
A second obstacle to progress in this field has been the lack of suitable animal models. Until recently, in vivo rodent models available to researchers studying corneal infection were limited to one that requires the cornea to be scratch injured to expose the stroma, and another in which bacteria are injected into the stroma. These models have been of great value in discerning the inflammatory and immune responses involved in disease and its resolution once an infection is already underway.8,12,15,16 However, these models bypass the corneal epithelium and are not suited to studying circumstances that surround the actual initiation of contact lens-related infection, or exploring why the cornea is resistant to infection when it is healthy. To study how bacteria interact with the corneal epithelium, we and others have used corneal epithelial cells grown in vitro. When attempting to do such experiments in vivo, one finds that bacteria do not interact at all with the epithelium of healthy corneas, leaving no pathology to study.17 The major obstacle interfering with the development of a good contact lens infection model has been a lack of availability of contact lenses that properly fit the eyes of small animals. Use of human lenses on larger animals (e.g., rabbits) poses similar problems and is also prohibitively expensive for generating sufficient data for statistical analysis. The hit and miss nature of research in this field has, in turn, made it difficult for investigators to obtain funding for basic biological research aimed at addressing pathogenesis of contact lens-related complications, further delaying progress.
Although these hurdles have prevented researchers from directly addressing key questions surrounding the pathogenesis of contact lens-related keratitis for almost 3 decades, we have recently entered a new era of discovery that could soon lead to the eradication of contact lens-related infections. This has come about through the development of rodent contact lenses18,19 (Fig. 1), and the advent of genomic sequencing of humans,20 of experimental animals,21 and of the microbes that are leading causes of contact lens- associated infection,22 combined with the recent development of new, highly sensitive, and readily available screening tools that can identify key molecules involved in critical biological processes (for example, those critical for defense and those impacted during susceptibility).23–26 Assisting these efforts are new methods in imaging and data analysis.27–30 For example, in our laboratory, we have developed novel in vivo and in vitro methods to study corneal defenses during health, which include new use of imaging technologies to enable us to “see” into living corneas so that we can observe bacteria in action while also monitoring the corneas' responses. Moreover, a plethora of new relevant information is arising daily from the use of these technologies in other related fields, e.g., studies of host-pathogen interactions and medical device-related infections in other tissues.31,32 Finally, because these new technologies are making research in this field more feasible (and also more interesting), leading researchers from related specialties have been attracted into the field, which will accelerate the effort. All these developments have ignited new optimism in the field.
This review will visit some key questions in this field, which we will attempt to answer based on published literature that include our own research on the topic over the past ∼20 years. In doing so, we will also project forward by presenting hypotheses about barriers to microbes in healthy corneas and how lens wear or bacteria may compromise them to enable infection.
Would it Help if Contact Lens Wearers were More Compliant?
Clearly, infection of the cornea requires a microbe(s). During contact lens wear, microbes can enter the eye from the wearer's lid margins, their fingers on lens insertion (or removal), or via the contact lens, and from the care solutions or the storage case. Proper use of a contact lens disinfection system (if it is effective) may reduce the probability of contamination, at least via some of these avenues. Conversely, improper use of lenses and their disinfection/cleaning systems (or lack of efficacy) could actually contribute to contamination by becoming an additional source. Although improper lens care has been associated with Acanthamoeba spp. keratitis in the United Kingdom, poor patient compliance is not always identified as a significant risk factor for microbial keratitis in contact lens wearers.5,6,33,34 This is not at all surprising considering that even the healthy non–lens-wearing ocular surface is frequently exposed to potentially pathogenic microbes (from the environment or from the patient themselves), yet the cornea rarely becomes infected. From this, we know that contamination does not equal infection. Although contamination of the ocular surface is necessary for infection to occur (obvious), it is not sufficient, and must be accompanied by changes in the way the microbes interact with the cornea, or in the way that the cornea responds to them.
Is there any value in improving user compliance? Generally speaking, it is thought that good hygiene minimizes microbial contamination and reduces the risk of infection and disease in other tissues and circumstances. Indeed, hand washing is considered as one of the most effective preventive approaches against infectious disease in general. Low efficacy of certain disinfection solutions (rather than non-compliance) was implicated in the Fusarium spp. and Acanthamoeba spp. keratitis outbreaks in lens wearers.35,36
Although the link between compliance and infection risk remains a gray area, improving contact lens care solutions, and education on their proper use, can only hurt if the solutions being used have undesirable side effects, e.g., they are toxic, impact immunity, or make surviving microbes more virulent or antibiotic resistant. It is important to recognize, however, that “hanging our hats” on improving patient compliance as a magic bullet approach to preventing infections could distract researchers in the field (and contact lens/solution manufacturers) from working toward more effective ways to eradicate the problem of contact lens-related infection. It may also provide practitioners and patients with a false sense of security. Importantly, good compliance will not sterilize the environment of the contact lens wearer. Disinfectants do not kill all microbes even when properly used, and there are many other sources of potentially pathogenic microbes in our environment that could provide an inoculum even if the lens, solution, storage case, and hands are all clean. Recent research shows that the number of bacteria colonizing a single human being is staggering, with bacterial cells outnumbering our own cells 10:1. Frequently encountered microbes can include Pseudomonas aeruginosa, Acanthamoeba spp., and Fusarium spp. (all leading causes of contact lens-related infections), which are ubiquitous in our environment (these live in water, food, and soil) and are not usually pathogenic.
An event that occurred recently in our laboratory provides an excellent example of how disinfection (and air drying) can fail to protect against infection. In that study, a “control group” of three lens-wearing rats (not deliberately inoculated with bacteria) became severely infected.37 The source was traced back to a suction device used to insert the lenses. Six months earlier, the device had been used with P. aeruginosa-contaminated contact lenses, before being disinfected with 70% ethanol (considered as a good disinfectant and expected to kill P. aeruginosa), air dried and then stored dry for the intervening 6 months. Incredibly, the same strain of P. aeruginosa (not grown in the laboratory since) was recovered from the device and from the rat's eyes and lenses. In other words, a few surviving ethanol-exposed and then air-dried bacteria managed to grow in vivo on a lens and then cause severe disease. Apart from showing the potential of bacteria to foil our best efforts, this outcome also suggests that the number of bacteria needed to cause an infection can be very small, possibly beyond the limits of Food and Drug Administration—approved kill rates for disinfection solutions. Further, this result combined with the other data, we have collected, showed that the usual infection delay of ∼7 days in rats can be reduced to ∼2 days if lenses are transferred from infected eyes to naïve rats, suggesting that the potential for microbes to cause keratitis may be dependent on the conditions they have been exposed to before entering the eye. This may also weigh into the equation when considering the impact of lens care solutions on the pathogenesis of infection.
In sum, there are logic gaps in viewing compliance as an effective way to prevent infection. Compliance will not ensure that solutions and lenses are sterile, and even if it did, there are other sources of microbes in the environment. Conversely, access of “pathogenic” microbes into the eye is not necessarily a problem because it also happens to non-lens wearers. It is likely that what happens to the eye during lens wear, or to the microbes before or after they gain access to the ocular surface, is key to the pathogenesis of contact lens-related infections and their eradication.
History shows that efforts toward improving patient compliance are generally in vain. This applies to drug therapy of life and sight-threatening diseases that include hypertension, diabetes, and glaucoma. Contact lens wearers are likely to have even less motivation for extra effort, particularly if they (or their friends or associates) have worn lenses for long periods of time and have not had any problems. Scare tactics such as graphic images of infections may not help, considering that horrific photos on cigarette packs have had little impact on smoking. It is of concern that efforts toward improving compliance with lens wear and existing disinfection procedures may delay progress toward understanding the fundamental causes of microbial keratitis, a path toward eliminating the problem.
Why is Extended Wear a Risk Factor?
Extended/overnight lens wear remains the most significant risk factor for infection.1,4,5,7 By using a rat model, we have found that disease onset is delayed by ∼1 week after a P. aeruginosa-contaminated lens is placed on the eye.37 We have been working toward understanding this delay in disease onset in rats, which we believe may provide clues as to why extended wear is a risk factor in people, and have found that during the “incubation period” classical bacterial biofilms form on the posterior, but not anterior, lens surface.37 Interestingly, if we transfer a lens from an infected eye (that already harbors bacterial biofilm) to a naïve rat, the delay is reduced to ∼2 days. Thus, bacteria that have already been in the eye as part of a biofilm on a lens are more adept at infecting the cornea. Subsequent experiments have confirmed that P. aeruginosa has the capacity to become more virulent with time if exposed to corneal epithelial cells, as demonstrated by alterations in gene expression and enhanced capacity to penetrate corneal epithelium both in vitro and in vivo (unpublished data). Thus, one reason that extended wear is a risk factor in people could be that it provides more time for bacteria to colonize the contact lens and adapt to the environment to become appropriately virulent.
Of course, it is also likely that lens wear impacts the ocular surface to reduce its defense against infection. As already discussed, the healthy cornea is remarkably resistant to microbes, so infection during lens wear may require more than just microbe adaptation. Indeed, our in vitro studies show that corneal epithelial cells grown in culture lose their normal ability to up-regulate expression of an antimicrobial peptide (hBD-2) in response to bacterial factors after they have been pre-exposed to hydrogel contact lens wear, but only if that exposure is for at least 72 hours.14 We have found similar results for surfactant protein-D (unpublished data), another factor involved in defense against infection at the ocular surface.17,38,39 If these in vitro data showing that cultured corneal epithelial cells lose their ability to respond appropriately to bacterial challenge after lens wear translate to human lens wear in vivo, then this is also likely to contribute to the reasons why extended wear is a risk factor for infection.
Another important factor to consider in this equation is the impact of contact lens wear on tear fluid, which we have found protects the corneal epithelial cells against P. aeruginosa.40–42 The mechanism of action of tears against microbes includes direct effects on microbes and also up regulation of the defensive capacity of epithelial cells. Indeed, one of the reasons why corneal epithelial cells are so exquisitely resistant to bacteria in vivo, while being completely vulnerable when grown in vitro, is likely to relate to the presence vs. absence of tear fluid. Tear fluid components are derived from multiple locations at and beyond the ocular surface. Thus, a contact lens has capacity to alter tear biochemistry at the corneal surface if it sits too close to the cornea (excludes tears) or if it shuts down exchange of tears (tear mixing) between the pre- and postlens tear compartments during blinking. The consequences of changes to ocular surface biochemistry could include loss of direct and/or indirect defenses against microbes. There could be other alterations to homeostasis with detrimental effects, such as epithelial injury induced by a postlens tear film, which exaggerates normal closed eye tears.25,43 In addition to impacting ocular surface biochemistry, lack of tear exchange may also reduce the ability to remove microbes from under the lens. During extended wear, this could enable sufficient time for microbes to adapt to the in vivo ocular surface environment, as discussed earlier. In this respect, it is of interest that infections are more common with soft lenses that enable less tear exchange during blinking than rigid gas-permeable (RGP) lenses.44 Also intriguing is that reverse geometry RGP lenses used for orthokeratology (that sit closer to the cornea at their center) have been found associated with a greater risk of infection (mostly P. aeruginosa) than conventional RGP lenses.45–47 During extended wear, there is likely to be even less opportunity for tear exchange, possibly relating to the increased risk of infection with overnight wear for all lens types.
Finally, compromise to unique defenses that protect the eye during eye closure may contribute to the reasons why extended contact lens wear is a risk factor for infection vs. daily wear. Indeed, it is known that the biochemistry of the closed eye ocular surface differs from that of the open eye, and these differences likely relate to defense against microbes.42 The effect of contact lens wear on closed eye defense against microbial virulence is certainly worthy of further investigation.
Are Antimicrobial Lenses a Good Idea?
Recently, there has been interest in coating lenses (or lens cases) with antimicrobial compounds as a strategy to reduce infection risk. As discussed earlier, our data collected by using a rat model suggest that bacterial attachment to contact lenses and subsequent biofilm formation could be critical for enabling bacteria to initiate infection. If this is also an important part of the pathogenic process during lens wear in people, blocking bacterial attachment to the posterior lens surface would be a good preventive strategy. Optimally, the strategy used would not kill microbes or inhibit their growth (provides selective pressure for resistance) and instead would target bacterial virulence, attachment, adaptation, or survival mechanisms.48 Good candidates include compounds with multiple diverse mechanisms of action to offset any resistance while offering opportunities for additive or synergistic effects. Of concern, would be agents that kill bacteria and are also used for treating infections (e.g., antibiotics) or components of our immune system (potential for serious adverse consequences).
It is clear that bacterial biofilm formation can occur in lens cases. Biofilms enable microbes within them to resist killing by antimicrobial agents and growth in biofilm format tends to make microbes more virulent, especially if exposed to adverse conditions.49–52 In designing lens cases to resist biofilm formation, it would be important to ensure that agents used do not further enhance microbe virulence (e.g., by using agents that stress, but do not kill microbes), and that toxic factors do not eventually end up in the eye. Regular case replacement would be an alternative strategy.
Does Fluorescein Staining Predict Risk of Infection?
Fluorescein staining indicates defects/compromise to the corneal epithelium. However, our data using various in vivo models show that fluorescein staining does not necessarily correlate with susceptibility to infection. For example, using a healing model of microbial keratitis, we showed that while injured corneas which had healed for either 6 or 12 hours both stained with fluorescein, only the 6-hour healed eyes were susceptible to infection.53 We have also found that tissue-paper blotting of the corneal surface of mice or rats that induces extensive fluorescein staining penetrating all the way into the stroma (confirmed by confocal microscopy) does not make the cornea susceptible to P. aeruginosa keratitis (unpublished data). In exploring the mechanism, our data reveal that the basal lamina (the basement membrane under the epithelium) is a barrier that prevents bacteria from entering the stroma.54 Moreover, while blotting allows P. aeruginosa to bind to surface epithelial cells (otherwise they do not bind at all), the bound bacteria do not penetrate beyond the most superficial layer of the epithelium. We are currently investigating the role of deeper layer junction proteins55 and epithelial-derived antimicrobial peptides56 in preventing bacterial traversal of blotted, fluorescein-permissive epithelium. Also of relevance, we have found that blotting has no impact on the pathogenesis of contact lens-induced keratitis in the rat model; the onset delay (of 1 week) and disease severity are similar for blotted and non-blotted eyes when they are subsequently fitted with a P. aeruginosa-contaminated lens.37 In summary, superficial blotting that enables fluorescein staining has no impact on outcome when bacteria are added to the eye with or without contact lens wear in rodent models.
Is Hypoxia a Risk Factor?
The introduction of silicone hydrogel lenses with superior oxygen transmissibility (high Dk/t) has not reduced the incidence of microbial keratitis5,57 but has solved other complications known to be hypoxia related.58 What conclusions can we draw from these studies? Although the data show that low-transmissibility lenses (low Dk/t) are not the only lenses that cause infection, can we actually conclude that hypoxia is not required? Do we really know that the ability to transmit oxygen through a lens translates to sufficient oxygen availability at the cellular level? Or that hypoxic response pathways in cells, that can be triggered by factors other than hypoxia,59 are not activated with silicone hydrogel wear? Even if hypoxia/hypoxic responses are really not needed for infection to occur, hypoxia could still contribute to pathogenesis. Indeed, the studies of Morgan et al.7 suggest that incidence of the most severe adverse events is actually reduced with silicone hydrogels when compared with hydrogels. Accordingly, in vivo studies have shown that lens-induced hypoxia can negatively impact corneal epithelial cell biology in various ways. For example, low-Dk RGP lenses induced a significant reduction in epithelial cell proliferation in the central cornea of rabbits compared with high-Dk rigid lenses, which closely mimicked normal corneas.60 In addition, hypoxia of low-Dk rigid lenses was associated with increased lipid raft formation in corneal epithelial cells and promotion of P. aeruginosa invasion.61 A study comparing low- vs. high-Dk hydrogel lenses in a rodent lens-wearing model showed reduced incidence of P. aeruginosa keratitis (no infections with high Dk vs. a 30% infection rate with low-Dk lenses) and significant proinflammatory changes in the cornea and conjunctiva involving low-Dk lenses.19 Other studies without lenses have also shown that hypoxia increases P. aeruginosa invasion of rabbit and human corneal epithelial cells and activation of a proinflammatory transcription factor.62 Thus, evidence suggests that hypoxia could impact susceptibility to infection, and that benefits of removing hypoxia with silicone hydrogel lens is masked by other lens-associated effects sufficient to allow infection. Alternatively, positive effects of removing hypoxia might be countered by undesirable negative effects. Indeed, some effects of hypoxia could actually be protective. For example, we have found that hypoxia increases corneal epithelial cell expression of surfactant protein-D, which serves protective and immunomodulatory roles.17,38,39,63,64
Why Pseudomonas aeruginosa?
Although other devastating microbes have come and gone in “outbreaks” (most recently Acanthamoeba spp. and Fusarium spp.), P. aeruginosa has been a staple consistent problem throughout the history of the soft lens. Indeed, before the introduction of soft contact lenses to the market, P. aeruginosa keratitis was a rare occurrence.
The capacity for P. aeruginosa to exploit the lens-wearing situation may relate to its large genome and the many genes devoted to virulence, survival, and adaptation. For example, it encodes >70 two-component “sensor-regulator” systems22 that enable it to alter gene expression to adapt to a multitude of diverse environments. Further, P. aeruginosa is ubiquitous in nature and is likely to access ocular tissues often in the course of our daily lives. As a “water bug,” all lens wearers can be exposed to it whether or not they use solutions. Although non-lens wearers have the benefits of blinking to regularly sweep the ocular surface, lens wear provides a means to increase contact time between microbe and the ocular surface to give those microbes with the right equipment a chance to adapt and exploit. In addition to having the right tools for sensing the environment, P. aeruginosa is known to encode many virulence factors with potential to enable survival at the ocular surface, including strategies for biofilm formation, for resisting killing, for communicating with one another to enhance virulence (e.g., quorum sensing), for invading epithelial cells and surviving within them, for destroying tear components, for breaking down cell-to-cell junctions and extracellular matrices, and for injecting toxins into cells.9,10,13,51,54,65–71 It also possesses factors that are highly immunogenic (initiate inflammation) while being able to evade the immune responses that it initiates.9,15,65,72 Interestingly, P. aeruginosa virulence factors can also confer resistance to contact lens disinfectants.73
What is the Relationship between Infection and Inflammation?
Contact lens wear can predispose to microbial keratitis, but it can also cause “sterile” inflammatory responses.58,74–76 Although there can be multiple presentations, these “sterile” events are all believed to involve inflammatory or toxic responses to immunogenic stimuli, such as microbes, or to microbial-derived factors. How different are these “sterile” events from actual infections? Is it possible that they represent similar processes of varying severity? Data obtained with the rat contact lens model show that there are two different outcomes when P. aeruginosa-contaminated lenses are placed on rat eyes. Disease onset is delayed by about 1 week in all eyes, but there are alternate presentations. Some eyes suffer severe disease that progresses quickly. Other eyes show milder opacity that develops slowly and does not progress substantially over time. When we examined severely infected corneas under the microscope, we found a severe inflammatory response and also large numbers of P. aeruginosa throughout the cornea. Although corneas showing milder opacity revealed a similar inflammatory response, we could not locate bacteria in the tissue (causative bacteria were found in large numbers only on and under the lens). At this stage, it is not clear whether the mild disease occurs because bacteria that have invaded the corneas are successfully cleared by the time we examine them or whether inflammation occurs without bacteria entering the cornea. Conversely, we also do not yet know whether the severely infected corneas become inflamed first, thereby creating the opportunity for bacteria to enter (e.g., inflammation can precede infection for Salmonella infection in the gut77,78). Nevertheless, these early results do suggest a relationship between infection and inflammation in etiology, even if they are not sequentially linked.
Why Not Just Advocate Daily Disposable Lenses?
Studies show that daily disposable or daily wear hydrogel lenses involve the lowest risks of microbial keratitis for soft lenses.5,57 Compliant use of daily disposables eliminates solution and lens case usage, and therefore related contamination and non- compliance. Thus, it is very informative that daily disposables do not substantially/consistently reduce the infection risk compared with conventional daily wear, which involves use of solutions. Either the use of solutions and cases does not impact susceptibility or else other factors associated with daily disposable use increase risk in other ways that cancel out the benefits. Whatever the case, these data provide further evidence that there is more to the pathogenesis of contact lens-related infection than just solution contamination and non-compliance, and that understanding lens-induced changes to normal ocular defenses against infection is warranted (Table 1, Fig. 2).
Continued research in the pathogenesis of microbial keratitis has significance beyond enabling us to understand contact lens infections. The study of how and why contact lens wear impacts ocular surface homeostasis advances our understanding of corneal health and disease in general. It also has the potential for development of novel methods to prevent infection of the eye and of other sites.
Of critical importance to the common goal of industry, practitioners, and patients alike to eradicate contact lens infections, is that the contact lens industry has started to provide rodent contact lenses to researchers allowing them to use directly relevant models to solve this problem. We urge the companies and other industry partners to continue to develop these important tools and make them widely available to the research community.
We thank the National Eye Institute and the National Institute for Allergy and Infectious Disease for continued support of our research program (EY011221, AI079192). We thank the Bill and Melinda Gates Foundation, Allergan, Inc., and Alcon Research, Inc for their generous research support. We also express our appreciation to our many colleagues in this field whose excellent work advances our understanding of microbial keratitis.
Suzanne M. J. Fleiszig
School of Optometry
University of California
688 Minor Hall
Berkeley, California 94720
1. Cheng KH, Leung SL, Hoekman HW, Beekhuis WH, Mulder PG, Geerards AJ, Kijlstra A. Incidence of contact-lens-associated microbial keratitis
and its related morbidity. Lancet 1999;354:181–5.
2. Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea
3. Ibrahim YW, Boase DL, Cree IA. Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol 2009;93:1319–24.
4. Edwards K, Keay L, Naduvilath T, Snibson G, Taylor H, Stapleton F. Characteristics of and risk factors for contact lens-related microbial keratitis
in a tertiary referral hospital. Eye (Lond) 2009;23:153–60.
5. Stapleton F, Keay L, Edwards K, Naduvilath T, Dart JK, Brian G, Holden BA. The incidence of contact lens-related microbial keratitis
in Australia. Ophthalmology 2008;115:1655–62.
6. Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses
. A case-control study. Microbial Keratitis
Study Group. N Engl J Med 1989;321:773–8.
7. Morgan PB, Efron N, Hill EA, Raynor MK, Whiting MA, Tullo AB. Incidence of keratitis of varying severity among contact lens wearers. Br J Ophthalmol 2005;89:430–6.
8. Hazlett LD. Corneal response to Pseudomonas aeruginosa
infection. Prog Retin Eye Res 2004;23:1–30.
9. Evans DJ, McNamara NA, Fleiszig SM. Life at the front: dissecting bacterial-host interactions at the ocular surface. Ocul Surf 2007;5:213–27.
10. Willcox MD. Pseudomonas aeruginosa
infection and inflammation during contact lens wear: a review. Optom Vis Sci 2007;84:273–8.
11. Pearlman E, Johnson A, Adhikary G, Sun Y, Chinnery HR, Fox T, Kester M, McMenamin PG. Toll-like receptors at the ocular surface. Ocul Surf 2008;6:108–16.
12. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus
: roles of alpha-toxin and protein A in pathogenesis. Infect Immun 1994;62:2478–82.
13. Fleiszig SM. The Glenn A. Fry award lecture 2005. The pathogenesis of contact lens-related keratitis. Optom Vis Sci 2006;83:866–73.
14. Maltseva IA, Fleiszig SM, Evans DJ, Kerr S, Sidhu SS, McNamara NA, Basbaum C. Exposure of human corneal epithelial cells to contact lenses
in vitro suppresses the upregulation of human beta-defensin-2 in response to antigens of Pseudomonas aeruginosa.
Exp Eye Res 2007;85:142–53.
15. Hazlett LD. Bacterial infections of the cornea
). Chem Immunol Allergy 2007;92:185–94.
16. O'Callaghan RJ, McCormick CC, Caballero AR, Marquart ME, Gatlin HP, Fratkin JD. Age-related differences in rabbits during experimental Staphylococcus aureus
keratitis. Invest Ophthalmol Vis Sci 2007;48:5125–31.
17. Mun JJ, Tam C, Kowbel D, Hawgood S, Barnett MJ, Evans DJ, Fleiszig SM. Clearance of Pseudomonas aeruginosa
from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun 2009;77:2392–8.
18. Szliter EA, Barrett RP, Gabriel MM, Zhang Y, Hazlett LD. Pseudomonas aeruginosa
-induced inflammation in the rat extended-wear contact lens model. Eye Contact Lens 2006;32:12–8.
19. Zhang Y, Gabriel MM, Mowrey-McKee MF, Barrett RP, McClellan S, Hazlett LD. Rat silicone hydrogel contact lens model: effects of high- versus low-Dk lens wear. Eye Contact Lens 2008;34:306–11.
20. Wain LV, Armour JA, Tobin MD. Genomic copy number variation, human health, and disease. Lancet 2009;374:340–50.
21. Brown SD, Hancock JM. The mouse genome. Genome Dyn 2006;2:33–45.
22. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV. Complete genome sequence of Pseudomonas aeruginosa
PAO1, an opportunistic pathogen. Nature 2000;406:959–64.
23. Borrebaeck CA, Wingren C. Design of high-density antibody microarrays for disease proteomics: key technological issues. J Proteomics 2009;72:928–35.
24. Morris KV. RNA-directed transcriptional gene silencing and activation in human cells. Oligonucleotides 2009;19:299–306.
25. Sack RA, Conradi L, Krumholz D, Beaton A, Sathe S, Morris C. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci 2005;46:1228–38.
26. Beutler B. The toll-like receptors: analysis by forward genetic methods. Immunogenetics 2005;57:385–92.
27. Bullen A, Friedman RS, Krummel MF. Two-photon imaging of the immune system: a custom technology platform for high-speed, multicolor tissue imaging of immune responses. Curr Top Microbiol Immunol 2009;334:1–29.
28. Sarris M, Betz AG. Shine a light: imaging the immune system. Eur J Immunol 2009;39:1188–202.
29. Rosenbaum JT, Planck SR, Martin TM, Crane I, Xu H, Forrester JV. Imaging ocular immune responses by intravital microscopy. Int Rev Immunol 2002;21:255–72.
30. Bousso P, Robey EA. Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy. Immunity 2004;21:349–55.
31. Musser JM, Shelburne SA, III. A decade of molecular pathogenomic analysis of group A Streptococcus
. J Clin Invest 2009;119:2455–63.
32. Lazazzera BA. Lessons from DNA microarray analysis: the gene expression profile of biofilms
. Curr Opin Microbiol 2005;8:222–7.
33. Najjar DM, Aktan SG, Rapuano CJ, Laibson PR, Cohen EJ. Contact lens-related corneal ulcers in compliant patients. Am J Ophthalmol 2004;137:170–2.
34. Radford CF, Bacon AS, Dart JK, Minassian DC. Risk factors for Acanthamoeba
keratitis in contact lens users: a case-control study. BMJ 1995;310:1567–70.
35. Joslin CE, Tu EY, Shoff ME, Booton GC, Fuerst PA, McMahon TT, Anderson RJ, Dworkin MS, Sugar J, Davis FG, Stayner LT. The association of contact lens solution use and Acanthamoeba
keratitis. Am J Ophthalmol 2007;144:169–80.
36. Khor WB, Aung T, Saw SM, Wong TY, Tambyah PA, Tan AL, Beuerman R, Lim L, Chan WK, Heng WJ, Lim J, Loh RS, Lee SB, Tan DT. An outbreak of Fusarium
keratitis associated with contact lens wear in Singapore. JAMA 2006;295:2867–73.
37. Tam C, Mun JJ, Evans DJ, Fleiszig SMJ. The impact of inoculation parameters on the pathogenesis of contact lens related infectious keratitis. Invest Ophthalmol Vis Sci 2010 Feb 3. [Epub ahead of print.]
38. Ni M, Evans DJ, Hawgood S, Anders EM, Sack RA, Fleiszig SM. Surfactant protein D is present in human tear fluid and the cornea
and inhibits epithelial cell invasion by Pseudomonas aeruginosa.
Infect Immun 2005;73:2147–56.
39. Ni M, Tam C, Verma A, Ramphal R, Hawgood S, Evans DJ, Fleiszig SM. Expression of surfactant protein D in human corneal epithelial cells is upregulated by Pseudomonas aeruginosa.
FEMS Immunol Med Microbiol 2008;54:177–84.
40. Fleiszig SM, Kwong MS, Evans DJ. Modification of Pseudomonas aeruginosa
interactions with corneal epithelial cells by human tear fluid. Infect Immun 2003;71:3866–74.
41. Kwong MS, Evans DJ, Ni M, Cowell BA, Fleiszig SM. Human tear fluid protects against Pseudomonas aeruginosa
keratitis in a murine experimental model. Infect Immun 2007;75:2325–32.
42. McNamara NA, Andika R, Kwong M, Sack RA, Fleiszig SM. Interaction of Pseudomonas aeruginosa
with human tear fluid components. Curr Eye Res 2005;30:517–25.
43. Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci 1992;33:626–40.
44. McNamara NA, Polse KA, Brand RJ, Graham AD, Chan JS, McKenney CD. Tear mixing under a soft contact lens: effects of lens diameter. Am J Ophthalmol 1999;127:659–65.
45. Shehadeh-Masha'our R, Segev F, Barequet IS, Ton Y, Garzozi HJ. Orthokeratology associated microbial keratitis
. Eur J Ophthalmol 2009;19:133–6.
46. Watt KG, Swarbrick HA. Trends in microbial keratitis
associated with orthokeratology. Eye Contact Lens 2007;33:373–7.
47. Chee EW, Li L, Tan D. Orthokeratology-related infectious keratitis: a case series. Eye Contact Lens 2007;33:261–3.
48. Zhu H, Kumar A, Ozkan J, Bandara R, Ding A, Perera I, Steinberg P, Kumar N, Lao W, Griesser SS, Britcher L, Griesser HJ, Willcox MD. Fimbrolide-coated antimicrobial lenses: their in vitro and in vivo effects. Optom Vis Sci 2008;85:292–300.
49. Drenkard E, Ausubel FM. Pseudomonas
biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002;416:740–3.
50. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009;11:1034–43.
51. Wagner VE, Iglewski BH. P. aeruginosa biofilms
in CF infection. Clin Rev Allergy Immunol 2008;35:124–34.
52. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:34–9.
53. Lee EJ, Evans DJ, Fleiszig SM. Role of Pseudomonas aeruginosa
ExsA in penetration through corneal epithelium
in a novel in vivo model. Invest Ophthalmol Vis Sci 2003;44:5220–7.
54. Alarcon I, Kwan L, Yu C, Evans DJ, Fleiszig SM. Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa
. Infect Immun 2009;77:3264–71.
55. Sosnova-Netukova M, Kuchynka P, Forrester JV. The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes. Br J Ophthalmol 2007;91:372–8.
56. McDermott AM. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res 2009;41:60–75.
57. Dart JK, Radford CF, Minassian D, Verma S, Stapleton F. Risk factors for microbial keratitis
with contemporary contact lenses
: a case-control study. Ophthalmology 2008;115:1647–54, 1654. e1–3.
58. Radford CF, Minassian D, Dart JK, Stapleton F, Verma S. Risk factors for nonulcerative contact lens complications in an ophthalmic accident and emergency department: a case-control study. Ophthalmology 2009;116:385–92.
59. Frede S, Berchner-Pfannschmidt U, Fandrey J. Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol 2007;435:405–19.
60. Ladage PM, Yamamoto K, Ren DH, Li L, Jester JV, Petroll WM, Bergmanson JP, Cavanagh HD. Proliferation rate of rabbit corneal epithelium
during overnight rigid contact lens wear. Invest Ophthalmol Vis Sci 2001;42:2804–12.
61. Yamamoto N, Jester JV, Petroll WM, Cavanagh HD. Prolonged hypoxia induces lipid raft formation and increases Pseudomonas
internalization in vivo after contact lens wear and lid closure. Eye Contact Lens 2006;32:114–20.
62. Zaidi T, Mowrey-McKee M, Pier GB. Hypoxia increases corneal cell expression of CFTR leading to increased Pseudomonas aeruginosa
binding, internalization, and initiation of inflammation. Invest Ophthalmol Vis Sci 2004;45:4066–74.
63. Kuroki Y, Takahashi M, Nishitani C. Pulmonary collectins in innate immunity
of the lung. Cell Microbiol 2007;9:1871–9.
64. McCormick CC, Hobden JA, Balzli CL, Reed JM, Caballero AR, Denard BS, Tang A, O'Callaghan RJ. Surfactant protein D in Pseudomonas aeruginosa
keratitis. Ocul Immunol Inflamm 2007;15:371–9.
65. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa
infection: lessons from a versatile opportunist. Microbes Infect 2000;2:1051–60.
66. Hauser AR. The type III secretion system of Pseudomonas aeruginosa
: infection by injection. Nat Rev Microbiol 2009;7:654–65.
67. Angus AA, Lee AA, Augustin DK, Lee EJ, Evans DJ, Fleiszig SM. Pseudomonas aeruginosa
induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motility. Infect Immun 2008;76:1992–2001.
68. Zolfaghar I, Evans DJ, Ronaghi R, Fleiszig SM. Type III secretion-dependent modulation of innate immunity
as one of multiple factors regulated by Pseudomonas aeruginosa
RetS. Infect Immun 2006;74:3880–9.
69. Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa
invades corneal epithelial cells during experimental infection. Infect Immun 1994;62:3485–93.
70. Zolfaghar I, Angus AA, Kang PJ, To A, Evans DJ, Fleiszig SM. Mutation of retS, encoding a putative hybrid two-component regulatory protein in Pseudomonas aeruginosa
, attenuates multiple virulence mechanisms. Microbes Infect 2005;7:1305–16.
71. Zolfaghar I, Evans DJ, Fleiszig SM. Twitching motility contributes to the role of pili in corneal infection caused by Pseudomonas aeruginosa.
Infect Immun 2003;71:5389–93.
72. Choy MH, Stapleton F, Willcox MD, Zhu H. Comparison of virulence factors in Pseudomonas aeruginosa
strains isolated from contact lens- and non-contact lens-related keratitis. J Med Microbiol 2008;57:1539–46.
73. Lakkis C, Fleiszig SM. Resistance of Pseudomonas aeruginosa
isolates to hydrogel contact lens disinfection correlates with cytotoxic activity. J Clin Microbiol 2001;39:1477–86.
74. Vijay AK, Sankaridurg P, Zhu H, Willcox MD. Guinea pig models of acute keratitis responses. Cornea
75. Sweeney DF, Jalbert I, Covey M, Sankaridurg PR, Vajdic C, Holden BA, Sharma S, Ramachandran L, Willcox MD, Rao GN. Clinical characterization of corneal infiltrative events observed with soft contact lens wear. Cornea
76. Morgan PB, Efron N, Brennan NA, Hill EA, Raynor MK, Tullo AB. Risk factors for the development of corneal infiltrative events associated with contact lens wear. Invest Ophthalmol Vis Sci 2005;46:3136–43.
77. Wall DM, Nadeau WJ, Pazos MA, Shi HN, Galyov EE, McCormick BA. Identification of the Salmonella enterica
serotype typhimurium SipA domain responsible for inducing neutrophil recruitment across the intestinal epithelium
. Cell Microbiol 2007;9:2299–313.
78. Criss AK, Silva M, Casanova JE, McCormick BA. Regulation of Salmonella
-induced neutrophil transmigration by epithelial ADP-ribosylation factor 6. J Biol Chem 2001;276:48431–9.
79. McNamara NA, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res 1999;69:483–90.
80. Fleiszig SM, Evans DJ, Do N, Vallas V, Shin S, Mostov KE. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa
invasion and cytotoxicity. Infect Immun 1997;65:2861–7.
Keywords:© 2010 American Academy of Optometry
microbial keratitis; Pseudomonas aeruginosa; cornea; epithelium; innate immunity; contact lenses; hygiene; biofilms